Annex II
E719365
Annex II is a section of the Cartagena Protocol on Biosafety that sets out detailed procedures and criteria for conducting risk assessments of living modified organisms.
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
annex
ⓘ
legal instrument section ⓘ |
| addresses |
potential adverse effects of living modified organisms on biological diversity
ⓘ
risks to human health related to living modified organisms ⓘ |
| adoptedUnder | Convention on Biological Diversity NERFINISHED ⓘ |
| appliesTo | living modified organisms ⓘ |
| basedOn |
available scientific and technical information
ⓘ
scientific evidence ⓘ |
| category |
biosafety regulation
ⓘ
international environmental law ⓘ |
| concerns |
biosafety
ⓘ
transboundary movement of living modified organisms ⓘ |
| defines |
general principles of risk assessment
ⓘ
methodological steps for risk assessment ⓘ points to consider in risk assessment ⓘ |
| encourages | transparent and documented risk assessment process ⓘ |
| entryIntoForceWith | Cartagena Protocol on Biosafety NERFINISHED ⓘ |
| governs | assessment of risks prior to transboundary movement of living modified organisms ⓘ |
| hasFunction | to guide Parties in conducting risk assessments under the Cartagena Protocol on Biosafety ⓘ |
| hasPurpose | to set out procedures and criteria for risk assessment of living modified organisms ⓘ |
| hasTitle | Risk Assessment ⓘ |
| languageOfText |
Arabic
ⓘ
Chinese ⓘ English ⓘ French ⓘ Russian ⓘ Spanish ⓘ |
| legalBasisIn |
Cartagena Protocol on Biosafety Article 15
NERFINISHED
ⓘ
Cartagena Protocol on Biosafety Article 16 NERFINISHED ⓘ |
| partOf | Cartagena Protocol on Biosafety NERFINISHED ⓘ |
| referencedBy |
national biosafety frameworks
ⓘ
risk assessment guidelines under the Cartagena Protocol on Biosafety ⓘ |
| regulates | risk assessment of living modified organisms ⓘ |
| relatedTo |
Annex I of the Cartagena Protocol on Biosafety
NERFINISHED
ⓘ
Annex III of the Cartagena Protocol on Biosafety NERFINISHED ⓘ |
| requiresConsiderationOf |
characteristics of the living modified organism
ⓘ
characteristics of the recipient or parental organisms ⓘ consequences of adverse effects ⓘ intended use of the living modified organism ⓘ likelihood of adverse effects ⓘ overall risk from living modified organisms ⓘ receiving environment ⓘ risk management strategies ⓘ |
| scopeIncludes |
case-by-case risk assessment
ⓘ
comparative assessment with recipient or parental organisms ⓘ scientific and technical risk assessment ⓘ |
| subjectTo | interpretation by Parties to the Cartagena Protocol on Biosafety ⓘ |
| usedBy | Parties to the Cartagena Protocol on Biosafety NERFINISHED ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.